Immunovant shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Immunovant
Tip: Access up to 7 years of quarterly data
All positions including Immunovant held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Immunovant by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $8.7M | 208k | 42.13 |
| 2023-09-30 | $3.2M | 83k | 38.39 |
| 2023-06-30 | $802k | 52k | 15.51 |
| 2023-03-31 | $802k | 52k | 15.51 |
| 2022-12-31 | $777k | 44k | 17.75 |
| 2022-09-30 | $208k | 37k | 5.58 |
| 2022-06-30 | $203k | 52k | 3.90 |
| 2022-03-31 | $286k | 52k | 5.51 |
| 2021-12-31 | $443k | 52k | 8.52 |
| 2021-09-30 | $451k | 52k | 8.69 |
| 2021-06-30 | $636k | 60k | 10.57 |
| 2021-03-31 | $699k | 44k | 16.04 |
| 2020-12-31 | $2.1M | 45k | 46.19 |
| 2020-09-30 | $704k | 20k | 35.19 |
| 2020-06-30 | $217k | 8.9k | 24.35 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas